Prospective Study Finds Potential Utility of MeMed’s Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients

Prospective Study Finds Potential Utility of MeMed’s Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients Rapid and Continuous Measurement of the Host-Immune Response with MeMed Key™ May Help Clinicians Predict COVID19 Disease Severity, Monitor Inflammatory Status and Guide Treatment Decisions    HAIFA, Israel, July 23rd, 2020 — Researchers at Israel’s Rabin Medical Center (comprised of Beilinson and […]

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform  Cutting-edge instrument platform and a novel host-immune response signature test rapidly distinguish between viral and bacterial infections to improve patient outcomes HAIFA, Israel, June 2, 2020 – MeMed Ltd., a leader in host response-based solutions, today announced that […]